Euromoney, is part of the Delinian Group, Delinian Limited, 8 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023
Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
OPINION

Zut alors! SocGen may face bigger equity derivatives challenges than peers

Weight a business towards structured products, and life can quickly get uncomfortable.

MB_banner_investment_banking-780

Selling volatility is a dangerous game. Having a little of it around is a good thing, to encourage clients to buy the stuff that your structured equity division churns out. Too much of it, however, and the hedges that sit behind that business can blow up in your face.

That’s what happened in the first quarter of 2020 at those French banks that make a business of selling structured products. But not all bad experiences were equal.

On paper, they looked similar enough. Revenues in the equities division at BNP Paribas fell to minus €87 million, a swing of nearly 120% in the wrong direction when compared with the first quarter of 2019. At Natixis, equities was minus-€32 million, a swing of 125%.

Frederic Oudea_2018_160x186

Frédéric Oudéa, Societe Generale

At Societe Generale, the business at least stayed in the black, with revenues of €9 million, for a fall of 99%.